ELRIG Drug Discovery 2026 has ended. This guide stays up as the record of who was there. Next: ELRIG DD 2027, Oct 19–20, 2027 in Liverpool

Start-ups and commercialisation at ELRIG Drug Discovery 2026

Oct 14–15, 2026 London, UK ~3k attendees Website

42 organizations at ELRIG Drug Discovery 2026 present work in start-ups and commercialisation: 30 technology and service providers, 9 academic, government and non-profit bodies and 3 drug developers. Between them they bring 21 presentations to the program. Most represented: LifeArc, Ignota Labs and Cancer Research Horizons. As of Oct 8, 2026.

All 388 organizations at ELRIG Drug Discovery 2026 →

Format
Top represented
Showing 1–18 of 42 organizations
OrganizationELRIG Drug Discovery 2026 Attendance
LifeArc
London, UK
◆Partner
Gov/NGOPartner
UK medical research charity that funds and runs translational research and drug discovery to move science toward patients.
Booth
Exhibiting at Booth CZ03
Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm
Chair
Wed Oct 14
9:20am–9:25am
Conference Director Welcome & Keynote Introduction
Engineering the cell microenvironment: Cell-based models for drug discovery · with Black Medical and Scientific Network, Novo Nordisk, Novartis
Talk
Wed Oct 14
9:25am–10:10am
Plenary Keynote - Where Need Meets Momentum: The Next 20 Years
Engineering the cell microenvironment: Cell-based models for drug discovery
Ignota Labs
Cambridge, UK
Biotech
AI company rescuing failed or shelved drug candidates by solving safety problems and creating new chemistry and IP.
Talk
Thu Oct 15
12:40pm–1:10pm
Giving failed drugs a second chance with AI
AI in medicinal chemistry
Panel
Thu Oct 15
3:30pm–4:00pm
Panel session - Beyond the Pitch: Navigating the Highs and Lows of Entrepreneurship
Breakthrough Zone - Bridging the critical gap between discovery and successful commercialisation · with Creasallis, MFX
Gov/NGO
Innovation arm of Cancer Research UK, turning academic cancer research into drugs, diagnostics and start-ups through partnerships and licensing.
Booth
Exhibiting at Booth C24
Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm
Chair
Wed Oct 14
11:15am–11:20am
Track Chair - Targeted potency: Advances in radioligands and bioconjugates
How radioligand therapies and bioconjugates deliver toxic payloads more precisely and safely to cancers that were once hard to treat.
Gov/NGO
UK national centre helping drug discovery entrepreneurs validate ideas and de-risk investment through its expertise, technology and national programmes.
Booth
Exhibiting at Booth G28
Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm
Talk
Wed Oct 14
4:15pm–4:30pm
Advancing Drug Discovery Through Radiopharmaceutical Innovation
Why radioactive drugs that both image and treat tumours can confirm a drug reaches its target, and what manufacturing hurdles remain.
Talk
Thu Oct 15
2:30pm–3:00pm
Mind the Gap: Maximising Sample Value from Collection to Translation - A new route to unlock the translational potential of human biological samples
From sample to translation: Solving the practical challenges of modern drug discovery
Creasallis
Cambridge, UK
Biotech
Develops a modification that helps antibodies and conjugates penetrate deeper into solid tumours, alongside its own oncology antibody programs.
Talk
Thu Oct 15
3:00pm–3:30pm
No Entry Required: How I Broke Into Building a Biotech When Antibodies Couldn't Break Into Tumours
Breakthrough Zone - Bridging the critical gap between discovery and successful commercialisation
Panel
Thu Oct 15
3:30pm–4:00pm
Panel session - Beyond the Pitch: Navigating the Highs and Lows of Entrepreneurship
Breakthrough Zone - Bridging the critical gap between discovery and successful commercialisation · with MFX, Ignota Labs
M
MFX
Stevenage, UK
Instruments & automation
Builds a closed, parallel instrument with continuous online monitoring for early cell therapy process development.
Talk
Thu Oct 15
2:30pm–3:00pm
Essentials for Founders: Getting Started, Financing, Product Development and Early Market Engagement
Breakthrough Zone - Bridging the critical gap between discovery and successful commercialisation
Panel
Thu Oct 15
3:30pm–4:00pm
Panel session - Beyond the Pitch: Navigating the Highs and Lows of Entrepreneurship
Breakthrough Zone - Bridging the critical gap between discovery and successful commercialisation · with Creasallis, Ignota Labs
Bioicus Lab
Harwell, UK
Consulting & other services
Consultancy building workflows, quality systems and product leadership to take life science discoveries to market; also manages licensable biological assets.
Consultancy Café table
Talk
Thu Oct 15
12:25pm–12:40pm
Consulting & other services
Venture capital firm backing early-stage deep-technology companies.
Panel
Thu Oct 15
12:25pm–1:10pm
Panel session - Backing the Breakthrough: Navigating the Funding Landscape for Early-Stage Life Sciences
Breakthrough Zone - Bridging the critical gap between discovery and successful commercialisation · with Macmillan Cancer Support, SV Health Investors
AB
Amilon Bio
Cambridge, UK
Consulting & other services
Venture creation company that builds biotech businesses from in-house ideas and external opportunities.
Chair
Thu Oct 15
10:50am–10:55am
Track Chair- Innovation Zone
How early-stage life science companies raise money, carry discoveries toward market and build portfolios, and where such efforts commonly fail.
with Isomorphic Labs
CI
Cam Innovations
Talk
Thu Oct 15
11:25am–11:55am
Portfolio Strategy - Turning a scientific platform into a prioritised commercial product pipeline
Breakthrough Zone - Bridging the critical gap between discovery and successful commercialisation
CellCodex
Cambridge, UK
CROs & CDMOs
Generates causal cell-perturbation data for AI drug discovery, using genome-wide screens in aged, disease-relevant human cell models.
Talk
Thu Oct 15
10:55am–11:25am
What Makes Technology Translate - Lessons from Scaling Science into a Company
Breakthrough Zone - Bridging the critical gap between discovery and successful commercialisation
GN
Gris Noir
Talk
Thu Oct 15
11:55am–12:25pm
How to become an AI-native company: operating models for the agentic era
Breakthrough Zone - Bridging the critical gap between discovery and successful commercialisation
Isomorphic Labs
London, UK
Biotech
AI drug discovery company, spun out of Google DeepMind, building predictive models to design new medicines.
Chair
Thu Oct 15
10:50am–10:55am
Track Chair- Innovation Zone
How early-stage life science companies raise money, carry discoveries toward market and build portfolios, and where such efforts commonly fail.
with Amilon Bio
Gov/NGO
UK cancer support charity with a venture investment arm, Macmillan Ventures.
Panel
Thu Oct 15
12:25pm–1:10pm
Panel session - Backing the Breakthrough: Navigating the Funding Landscape for Early-Stage Life Sciences
Breakthrough Zone - Bridging the critical gap between discovery and successful commercialisation · with SV Health Investors, Amadeus Capital Partners
Consulting & other services
Specialist healthcare fund manager investing in life science and healthcare companies across stages.
Panel
Thu Oct 15
12:25pm–1:10pm
Panel session - Backing the Breakthrough: Navigating the Funding Landscape for Early-Stage Life Sciences
Breakthrough Zone - Bridging the critical gap between discovery and successful commercialisation · with Macmillan Cancer Support, Amadeus Capital Partners
Mathys & Squire
London, UK
Consulting & other services
Full-service intellectual property firm handling patents, trade marks, designs and litigation for technology-rich businesses.
Innovation Prize sponsor
Workshop sponsor
Workshop
Thu Oct 15
1:25pm–2:05pm
From innovation to investment: Building an investable IP strategy
Breakthrough Zone - Bridging the critical gap between discovery and successful commercialisation
Consulting & other services
Regulatory affairs consultancy offering interim senior leadership, global development strategy and mentoring to biotech and pharma companies.
Consultancy Café table
Atomixel
London, UK
Consulting & other services
Independent consultancy advising life science firms on which tools to adopt or build, drawing on microfluidics, single-cell and product development expertise.
Consultancy Café table

Explore the full ELRIG Drug Discovery 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in London. Leave your work email and we’ll be in touch.

Privacy

Download the full ELRIG Drug Discovery 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers in start-ups and commercialisation

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Browse ELRIG Drug Discovery 2026 by

Exhibit hall

Not affiliated with or endorsed by ELRIG. Submit a correction